BHCM
PRCT icon

Boulder Hill Capital Management’s Procept Biorobotics PRCT Stock Holding History

Boulder Hill Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,900
Closed -$245K – 197
2022
Q4 		$245K Buy
+5,900
New +$253K 0.2% 100

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Boulder Hill Capital Management's PRCT Position: Q1 2023 in Review

Boulder Hill Capital Management sold out of Procept Biorobotics (PRCT) in Q1 2023, closing a stake of 5,900 shares — an estimated $245K sold.

Boulder Hill Capital Management first reported a position in PRCT in Q4 2022 and held it in 1 quarter. The position peaked at $245K in Q4 2022. 116 funds tracked by Wall St. Rank hold PRCT as of Q1 2023.

  • Boulder Hill Capital Management reported no remaining Procept Biorobotics position as of Q1 2023 after selling out during the quarter.
  • Boulder Hill Capital Management sold 5,900 Procept Biorobotics shares in Q1 2023, an estimated $245K.
  • Boulder Hill Capital Management first reported a position in Procept Biorobotics in Q4 2022 and held it in 1 quarter.
  • Boulder Hill Capital Management's Procept Biorobotics position peaked at $245K in Q4 2022.
  • 116 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2023.

Based on Boulder Hill Capital Management's 13F filing for Q1 2023, filed 12 May 2023.